ZANINOTTO, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 9.435
EU - Europa 840
AS - Asia 528
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 10.809
Nazione #
US - Stati Uniti d'America 9.426
CN - Cina 456
FI - Finlandia 211
SE - Svezia 165
UA - Ucraina 144
DE - Germania 125
IT - Italia 86
GB - Regno Unito 62
VN - Vietnam 55
IE - Irlanda 26
IN - India 8
CU - Cuba 7
FR - Francia 7
GR - Grecia 6
NL - Olanda 5
TR - Turchia 4
EU - Europa 2
IR - Iran 2
AR - Argentina 1
BZ - Belize 1
CA - Canada 1
DZ - Algeria 1
JP - Giappone 1
PH - Filippine 1
PL - Polonia 1
RS - Serbia 1
RU - Federazione Russa 1
SC - Seychelles 1
SG - Singapore 1
VE - Venezuela 1
Totale 10.809
Città #
Fairfield 1.700
Woodbridge 996
Houston 830
Jacksonville 725
Ashburn 674
Chandler 654
Seattle 622
Wilmington 622
Cambridge 568
Ann Arbor 528
Princeton 277
San Diego 179
Beijing 115
Roxbury 101
Nanjing 92
Helsinki 75
Des Moines 74
Dong Ket 55
Boardman 51
Medford 49
Shenyang 40
Padova 39
Guangzhou 34
Dublin 26
Nanchang 26
Hebei 25
New York 23
Norwalk 22
Jiaxing 18
Falls Church 17
Los Angeles 15
Changsha 14
Jinan 13
Tianjin 12
Ogden 11
London 10
Redwood City 10
Ningbo 8
Shanghai 8
Washington 8
Havana 7
Borås 6
College Station 6
Kharkiv 6
Kunming 6
Hanover 5
Pune 5
Taizhou 5
Columbus 4
Indiana 4
Manchester 4
New Bedfont 4
Yellow Springs 4
Yenibosna 4
Chicago 3
Feltre 3
Ferentino 3
Haikou 3
Hounslow 3
Islington 3
Kilburn 3
Milan 3
Rome 3
Taiyuan 3
Buffalo 2
Detroit 2
Fort Worth 2
Geislingen an der Steige 2
Genoa 2
Groningen 2
Hangzhou 2
Hefei 2
Lanzhou 2
Las Vegas 2
Linköping 2
Longobucco 2
Mashhad 2
Nanning 2
Rockville 2
Rovigo 2
Simi Valley 2
Tappahannock 2
Zhengzhou 2
Almere Stad 1
Atlanta 1
Belize City 1
Blida 1
Caracas 1
Carmichael 1
Costa Mesa 1
Fuzhou 1
Kladovo 1
Lincoln 1
Mahé 1
Manila 1
Monmouth Junction 1
Munich 1
North York 1
Orange 1
Phoenix 1
Totale 9.521
Nome #
Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases 146
The Veneto Region's Barrett's Oesophagus Registry: Aims, methods, preliminary results. 141
The preoperative manometric pattern predicts the outcome of surgical treatment for esophageal achalasia. 140
Role of proton pump inhibitor on esophageal carcinogenesis and pancreatic acinar cell metaplasia development: an experimental in vivo study. 135
ALTERED ESOPHAGEAL PAIN THRESHOLD IN IRRITABLE-BOWEL-SYNDROME 129
SEQUENTIAL INTRALUMINAL ENDOSCOPIC AND LAPAROSCOPIC TREATMENT FOR BILE DUCT STONES ASSOCIATED WITH GALLSTONES. 126
Therapeutic Strategies for Epiphrenic Diverticula: Systematic Review 124
Diffuse esophageal spasm: the surgical approach 122
Barrett's epithelium after antireflux surgery 119
The role of botulinum toxin injection and upper esophageal sphincter myotomy in treating oropharyngeal dysphagia 118
Oesophageal resection for high-grade dysplasia in Barrett's oesophagus 116
Radiological evidence of subclinical dysphagia in motor neuron disease 116
Long-term outcome of operated and unoperated epiphrenic diverticula 115
Laparoscopic Heller myotomy can be used as primary therapy for esophageal achalasia regardless of age 113
Programmed cell death 4 nuclear loss and miR-21 or activated Akt overexpression in esophageal squamous cell carcinogenesis. 112
Oxidative DNA Damage in Barrett Mucosa: Correlation with Telomeric Dysfunction and p53 Mutation. 111
Aurora kinase A in Barrett's carcinogenesis. 111
Programmed cell death 4 protein in esophageal cancer 110
Herpes simplex Virus type 1 Infection of the Rat Enteric Nervous System Evokes Small Bowel Neuromuscular Abnormalities. 109
Long-term outcome and risk of oesophageal cancer after surgery for achalasia. 108
Esophageal achalasia: Is the herpes simplex virus really innocent? 107
Erosion of an esophageal endoprosthesis into the trachea 105
MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia. 104
Anterior gradient 2 profiling in Barrett columnar epithelia and adenocarcinoma. 102
The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis. 100
Human epithelial growth factor receptor 2 (HER2) status in primary and metastatic esophagogastric junction adenocarcinomas. 98
MicroRNA expression profiling in human Barrett's carcinogenesis. 98
CDX2 hox gene product in a rat model of esophageal cancer 97
Laparoscopic live donor nephrectomy: Single center experience 97
Zenker's Diverticula: Feasibility of a Tailored Approach Based on Diverticulum Size 96
Intestinal or gastric? The unsolved dilemma of Barrett's metaplasia 95
Esophageal motor function in patients with myotonic dystrophy 94
Altered intestinal motility following enteric nervous system infection by Herpes Simplex Virus 1 94
Barrett's registries in Europe: report of an international workshop 93
Altered Intestinal Motility Following Enteric Nervous System Infection by Herpes Simplex Virus Type 1 is Related to Gut Neuroanatomical and Neurochemical Abnormalities 93
T cells in the myenteric plexus of achalasia patients show a skewed TCR repertoire and react to HSV-1 antigens 92
ONE YEAR FOLLOW-UP AFTER LAPAROSCOPIC HELLER-DOR OPERATION FOR ESOPHAGEAL ACHALASIA 90
Esophageal GIST: Case report of surgical enucleation and update on current a diagnostic and therapeutic options 90
Etiology, diagnosis and treatment of failures after laparoscopic Heller Myotomy for achalasia 89
Endoscopic and surgical management of achalasia 87
Gastric precancerous lesion follow up based on pathological evidence 87
Successful treatment of long-standing post-stroke dysphagia with botulinum toxin and rehabilitation 87
Randomized controlled trial of botulinum toxin versus laparoscopic heller myotomy for esophageal achalasia 85
Achalasia: Pneumatic Dilation or Laparoscopic Heller Myotomy? 85
Long-term follow-up of Barrett's epithelium: medical versus antireflux surgical therapy. 84
Squamous cell carcinoma antigen (SCCA) is up-regulated during Barrett's carcinogenesis and predicts esophageal adenocarcinoma resistance to neoadjuvant chemotherapy 84
Minimally invasive enucleation of esophageal leiomyoma 84
Surgical options and outcomes in Barrett's esophagus 83
ESOPHAGEAL ACHALASIA - LAPAROSCOPIC VERSUS CONVENTIONAL OPEN HELLER-DOR OPERATION 82
Surgical management of refractory gastro-oesophageal reflux 81
Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma 81
Oesophageal diverticula 80
Botulinum toxin injection versus laparoscopic myotomy for the treatment of esophageal achalasia: economic analysis of a randomized trial 80
Laparoscopic Re-Do Myotomy for Recurrent Achalasia After Heller-Dor Procedure 80
The short esophagus: Intraoperative assessment of esophageal length 80
Re: Risk of Malignant Progression in Barrett's Esophagus Patients: Results from a Large Population-Based Study. 79
Pseudoachalasia: not only esophago-gastric cancer 78
Laparoscopic Repair of Epiphrenic Diverticulum 78
Mediastinal carcinosis involving the esophagus in breast cancer: the"breast-esophagus" syndrome: report on 25 cases and guidelines for diagnosis andtreatment. 77
The never-ending story of dilatation versus surgery for oesophageal achalasia 77
Toll-like Receptor 2 Regulates Intestinal Inflammation by Controlling Integrity of the Enteric Nervous System 77
Achalasia and esophago-gastric junction outflow obstruction: focus on the subtypes 77
Shorter myotomy on the gastric site (≤2.5 cm) provides adequate relief of dysphagia in achalasia patients 77
Objective follow-up after laparoscopic repair of large type III hiatal hernia. Assessment of safety and durability 76
Early HER2 dysregulation in gastric and oesophageal carcinogenesis. 76
Long-term results (6-10 years) of laparoscopic fundoplication 76
Helicobacter pylori, inflammation, oxidative damage and gastric cancer: a morphological, biological and molecular pathway. 76
DNA copy number alterations correlate with survival in esophageal adenocarcinoma patients. 76
Endoscopic treatment of gastroesophageal reflux disease 75
Barrett’s Esophagus and Adenocarcinoma Risk The Experience of the North-Eastern Italian Registry (EBRA) 75
Surgical complications do not affect longterm survival after esophagectomy for carcinoma of the thoracic esophagus and cardia. 74
Long-term outcome of laparoscopic Heller-Dor surgery for esophageal achalasia: Possible detrimental role of previous endoscopic treatment 74
Selected Commentary to "Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia" 74
Re: CDX2 homeotic gene expression in gastric noninvasive neoplasia 71
The Kagoshima consensus on esophageal achalasia 71
MicroRNA Dysregulation in Esophageal Neoplasia: The Biological Rationale for Novel Therapeutic Options. 71
Objective follow-up after laparoscopic repair of large type III hiatal hernia: Assessment of safety and durability - Reply 70
Esophageal Achalasia in the Veneto Region: Epidemiology and Treatment Epidemiology and Treatment of Achalasia 70
Pericentriolar material analyses in normal esophageal mucosa, Barrett's metaplasia and adenocarcinoma 70
Manometric characteristics of the distal oesophageal sphincter and patterns of gastro-oesophageal reflux in healthy volunteers and patients 70
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis. 70
Chylothorax complicating esophagectomy for cancer: A plea for early thoracic duct ligation 69
Pneumatic Dilation versus Laparoscopic Heller's Myotomy for Idiopathic Achalasia 69
Minimally invasive surgery for esophageal achalasia 69
ESOPHAGITIS AND PH OF THE REFLUXATE - EXPERIMENTAL AND CLINICAL-STUDY 68
Management of minimally symptomatic pulsion diverticula of the esophagus 68
Barrett's Esophagus: Still Much to Learn, But "Yes, We Can!" 68
Tailored approach to Zenker's diverticula 68
Results of esophagectomy for esophageal cancer in elderly patients: Age has little influence on outcome and survival 68
The Myotomy Length on the Gastric Side Doesn't Influence the Final Outcome of Laparoscopic Heller Dor for Esophageal Achalasia 68
Prevalence of intestinal metaplasia in the distal oesophagus, oesophagogastric junction and gastric cardia in symptomatic patients in north-east Italy: a prospective, descriptive survey 67
Barrett's epithelium after antireflux surgery 65
Functional and morphological study of the cricopharyngeal muscle in patients with Zenker's diverticulum 63
The role of a defective lower esophageal sphincter in the clinical outcome of treatment for gastroesophageal reflux disease 63
The Fate of Barrett's Epithelium Under Acid Suppression Obtained by Medical or Surgical Therapy 63
Long-term results of the European Achalasia trial: A multicentre randomised Controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy 63
Long‐Term pH and Manometric Evaluation of the Distal Esophagus After Endoscopic Sclerotherapy of Esophageal Varices 61
Circulating microRNA expression profiling revealed miR-92a-3p as a novel biomarker of Barrett's carcinogenesis 61
Laparoscopic treatment of lymphocele after kidney transplantation. 60
Barrett's esophagus: management of high-grade dysplasia and cancer 60
Totale 8.761
Categoria #
all - tutte 34.807
article - articoli 33.734
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 360
Totale 68.901


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019880 0 0 0 0 0 0 0 0 0 192 370 318
2019/20202.958 380 230 80 231 273 206 244 326 320 324 204 140
2020/20211.742 139 134 159 126 33 115 85 196 275 176 169 135
2021/20222.022 65 178 260 140 113 106 81 248 172 37 238 384
2022/20231.310 310 134 28 147 215 187 0 82 163 0 37 7
2023/2024471 46 85 76 43 34 71 25 33 31 27 0 0
Totale 10.878